| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Sk Biopharmaceuticals Co Ltd (KO: 326030)
326030 Technical Analysis
4
| As on 27th Mar 2026 326030 STOCK Price closed @ 100300.00 and we RECOMMEND Sell for LONG-TERM with Stoploss of 104281.97 & Strong Sell for SHORT-TERM with Stoploss of 110670.91 we also expect STOCK to react on Following IMPORTANT LEVELS. |
326030STOCK Price
| Open | 103500.00 | Change | Price | % |
| High | 103700.00 | 1 Day | 5600.00 | 5.91 |
| Low | 96300.00 | 1 Week | 1500.00 | 1.52 |
| Close | 100300.00 | 1 Month | -9400.00 | -8.57 |
| Volume | 513839 | 1 Year | -2700.00 | -2.62 |
| 52 Week High 140700.00 | 52 Week Low 88500.00 | ||||
KO Korea Most Active Stocks
| 093230 | 33.00 | -49.23% |
| 093230 | 33.00 | -49.23% |
| 014160 | 1300.00 | -7.74% |
| 014160 | 1300.00 | -7.74% |
| 047040 | 17260.00 | 8.55% |
| 047040 | 17260.00 | 8.55% |
| 001510 | 2070.00 | -0.96% |
| 001510 | 2070.00 | -0.96% |
| 152550 | 383.00 | 19.69% |
| 152550 | 383.00 | 19.69% |
KO Korea Top Gainers Stocks
KO Korea Top Losers Stocks
| 326030 Daily Charts |
326030 Intraday Charts |
Whats New @ Bazaartrend |
326030 Free Analysis |
|
|
326030 Important Levels Intraday
| RESISTANCE | 114559.80 |
| RESISTANCE | 109986.60 |
| RESISTANCE | 107159.80 |
| RESISTANCE | 104333.00 |
| SUPPORT | 96267.00 |
| SUPPORT | 93440.20 |
| SUPPORT | 90613.40 |
| SUPPORT | 86040.20 |
326030 Forecast March 2026
| 4th UP Forecast | 154063 |
| 3rd UP Forecast | 136821 |
| 2nd UP Forecast | 126163 |
| 1st UP Forecast | 115506 |
| 1st DOWN Forecast | 85094.5 |
| 2nd DOWN Forecast | 74436.7 |
| 3rd DOWN Forecast | 63778.9 |
| 4th DOWN Forecast | 46536.7 |
326030 Weekly Forecast
| 4th UP Forecast | 121304.30 |
| 3rd UP Forecast | 114568.10 |
| 2nd UP Forecast | 110404.30 |
| 1st UP Forecast | 106240.50 |
| 1st DOWN Forecast | 94359.50 |
| 2nd DOWN Forecast | 90195.70 |
| 3rd DOWN Forecast | 86031.90 |
| 4th DOWN Forecast | 79295.70 |
326030 Forecast2026
| 4th UP Forecast | 210524 |
| 3rd UP Forecast | 175175 |
| 2nd UP Forecast | 153324 |
| 1st UP Forecast | 131474 |
| 1st DOWN Forecast | 69126 |
| 2nd DOWN Forecast | 47275.6 |
| 3rd DOWN Forecast | 25425.2 |
| 4th DOWN Forecast | -9924.4 |
Sk Biopharmaceuticals Co Ltd ( KO Korea Symbol : 326030 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
326030 Business Profile
SK Biopharmaceuticals Co., Ltd., a pharmaceutical company, engages in the research, discovery, and development of drugs for the treatment of central nervous system disorders. The company is developing Cenobamate for the treatment of epilepsy; Solriamfetol for the treatment of excessive daytime sleepiness in narcolepsy or obstructive sleep apneal; Carisbamate that is in Phase 1b/2 trials to treat lennox-gastaut syndrome; and Relenopride, which is in Phase 2 clinical trials to treat rare neurological disease. It is also developing SKL13865 that is in Phase 1 clinical trials to treat attention deficit/hyperactivity disorder; SKL20540, which is in Phase 1 clinical trials for the treatment of schizophrenia; SKL-PSY that is in Phase 1 clinical trials to treat bipolar disorder; and SKL24741, which is in Phase 1 clinical trials for the treatment of epilepsy. The company was founded in 2011 and is headquartered in Seongnam, South Korea. SK Biopharmaceuticals Co., Ltd. operates as subsidiary of SK Holdings Co., Ltd. Address: 221, Pangyoyeok-ro, Seongnam-si, South Korea, 13494
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service